Randomized phase II Trial of combined chemoradiation with Epidermal Growth Factor Receptor (EGFR) antagonist Cetuximab versus combined chemoradiation with EGFR antagonist Cetuximab and sequential Cetuximab for patients with locally advanced pancreatic adenocarcinoma

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2005
This article has no abstract
Epistemonikos ID: e59bd22116b8ffd57a8501c20a297af36ccd68d9
First added on: Jan 17, 2025